ArticleFrontiers in immunology2025

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.

Michael Hecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.